Cargando…
Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy
Cell membrane- covered drug-delivery nanoplatforms have been garnering attention because of their enhanced bio-interfacing capabilities that originate from source cells. In this top-down technique, nanoparticles (NPs) are covered by various membrane coatings, including membranes from specialized cel...
Autores principales: | Gong, Chunai, Yu, Xiaoyan, You, Benming, Wu, Yan, Wang, Rong, Han, Lu, Wang, Yujie, Gao, Shen, Yuan, Yongfang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298843/ https://www.ncbi.nlm.nih.gov/pubmed/32546174 http://dx.doi.org/10.1186/s12951-020-00649-8 |
Ejemplares similares
-
Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles
por: Gong, Chunai, et al.
Publicado: (2021) -
Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma
por: Li, Zhe, et al.
Publicado: (2021) -
Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2021) -
A ferroptosis-inducing biomimetic nanocomposite for the treatment of drug-resistant prostate cancer
por: Chen, Jiyuan, et al.
Publicado: (2022) -
Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy
por: Jiang, Wenjun, et al.
Publicado: (2020)